Published: 2020-12-24

Post radiotherapy, blue naevus conversion to basal cell carcinoma

Manish Munjal, Sandhya Sood, Porshia Rishi, Harjinder Sidhu, Shubham Munjal, Shivam Talwar, Salony Sharma, Avantika Garg


Post-radiation conversion of benign cutaneous lesions to malignant is likely in the facial region. Thereby counselling and necessity of regular follow up is essential in patients undergoing radiotherapy in head and neck malignancies. Benign lesions undergo malignant change more so in the fascio cutaneous planes. A benign nasomaxillary blue naevus that transformed to malignant basal cell carcinoma following radiotherapy for pituitary adenoma is being reported.


Radiation induced secondary malignancy, Blue naevus, Pituitary adenoma, Basal cell carcinoma, Radiotherapy

Full Text:



Rienstein S, Loven D, Israeli O, Ram Z, Rappaport ZH, Barkai G et al. Comparative genomic hybridization analysis of radiation-associated and sporadic meningiomas. Cancer Genet Cytogenet. 2001;131(2):135-40.

Gandhi SA, Kampp J. Skin Cancer Epidemiology, Detection, and Management. The Medical Clinics of North America. 2015;99(6):1323-35.

Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book. 2014;e57-67.

Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083-95.

Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21:1-201.

Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449-56.

Sadamori N, Shibata S, Mine M, Miyazaki H, Miyake H, Kurihara M et al. Incidence of intracranial meningiomas in Nagasaki atomic-bomb survivors. Int J Cancer. 1996;67:318-322.

Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 1994;137(2):S17-S67.

Ron E, Preston DL, Mabuchi K, Thompson DE, Soda M. Cancer incidence in atomic bomb survivors. Part IV: comparison of cancer incidence and mortality. Radiat Res. 1994;137(2):S98-S112.

Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):263-68.

Jones EW, Heyl T. Naevus sebaceus. A report of 140 cases with special regard to the development of secondary malignant tumours. Br J Dermatol. 1970;82:99-117.

Murthy V, Gurram L, Kannan S, Gandhi M, Gupta T, Laskar SG et al. Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity. Adv Radiat Oncol. 2017;2(3):339-45.

Czyz CN, Cahill KV, Foster JA, Michels KS, Clark CM, Rich NE. Reconstructive options for the medial canthus and eyelids following tumor excision. Saudi J Ophthalmol. 2011;25(1):67-74.

Brizel DM, Wasserman TH, Henke M. Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer. J Clin Oncol. 2000;18:3339-346.